Many women feel a lump in their breast or receive an abnormal result on a screening mammogram that turns out to be a cyst or other type of non-cancerous growth.
A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven't responded to other treatments, according to a pair of clinical trials.
Out-of-pocket costs may make as many as 1 in 5 women forgo additional screening when an initial mammogram finds an abnormality, a new U.S. study finds.
